Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)

Clinical trial NCT00545584 · COMPLETED

Trial details

NCT number: NCT00545584
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Non-Insulin-Dependent

Start date: 2007-04-01
Primary completion: 2009-11-19
Enrollment: 1512

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.